Roles of Inflammasome in Cigarette Smoke-Related Diseases and Physiopathological Disorders: Mechanisms and Therapeutic Opportunities
Overview
Authors
Affiliations
Cigarette smoke damages a wide range of immunological functions, including innate and adaptive immune responses. Emerging literature demonstrates that inflammasome constitutes an essential component in innate immune response. In this review, we focus on the cumulative mechanisms of inflammasome in cigarette smoke-related diseases and physiopathological disorders, and summarize potential therapeutic opportunities targeting inflammasome. This review suggests that inflammasomes (NLRP3, NLRP6, NLRP12 and AIM2) are involved in the pathogenesis of several cigarette smoke-related diseases (including COPD, ALI, atherosclerosis, kidney injury, bladder dysfunction, and oral leukoplakia) and physiopathological disorders (macrophage dysfunction, endothelial barrier dysfunction, podocyte injury, and ubiquitin-mediated proteasomal processing). MyD88/NF-κB, HMGB1, production of ROS, endoplasmic reticulum stress and mitochondrial dysfunction, and Ca influx are potentially involved in cigarette smoke induced-inflammasome activation. Strategies targeting ROS/NLRP3 inflammasome axis are most widely investigated and show potential therapeutic effects.
Li Y, Shen Q, Chen C, Yin X, Wang X, Yang X Front Nutr. 2025; 12:1533193.
PMID: 40008315 PMC: 11852840. DOI: 10.3389/fnut.2025.1533193.
Effect of Cigarette Smoking on Clinical and Molecular Endpoints in COPD Patients.
Russo P, Milani F, De Iure A, Proietti S, Limongi D, Prezioso C Int J Mol Sci. 2024; 25(11).
PMID: 38892022 PMC: 11172087. DOI: 10.3390/ijms25115834.
Yu Y, Miao T, Xiao W, Mao B, Du L, Wang Y Drug Des Devel Ther. 2024; 18:1755-1770.
PMID: 38808326 PMC: 11131956. DOI: 10.2147/DDDT.S445788.
Liu W, Higashikuni Y Hypertens Res. 2023; 47(3):799-802.
PMID: 38114653 DOI: 10.1038/s41440-023-01545-y.
Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities.
Ortega M, De Leon-Oliva D, Garcia-Montero C, Fraile-Martinez O, Boaru D, Velazquez De Castro A Front Immunol. 2023; 14:1232629.
PMID: 37545507 PMC: 10402745. DOI: 10.3389/fimmu.2023.1232629.